Literature DB >> 15148244

Hypericum perforatum L (St John's wort) preferentially increases extracellular dopamine levels in the rat prefrontal cortex.

Takashi Yoshitake1, Ryuji Iizuka, Shimako Yoshitake, Pia Weikop, Walter E Müller, Sven Ove Ogren, Jan Kehr.   

Abstract

The effects of hydro-alcoholic extracts of Hypericum perforatum L on extracellular serotonin (5-HT), noradrenaline (NA) and dopamine (DA) levels and the acidic metabolites (3,4-dihydroxyphenylacetic acid (DOPAC), homovanillic acid (HVA) and 5-hydroxy-3-indoleacetic acid (5-HIAA)) were examined by in vivo microdialysis in the prefrontal cortex of awake rats. Thus, a single dose (60 mg kg(-1) i.p. or 300 mg kg(-1) p.o.) of H. perforatum increased DA concentrations to 165 and 140% of control values, respectively, and increased locomotor activity in nonhabituated rats. DOPAC and HVA levels were markedly reduced. 5-HT concentrations were elevated only moderately, while the NA levels were not affected by any treatment. The whole-tissue analysis revealed that hypericum increased, whereas the monoamine oxidase (MAO) A/B inhibitor phenelzine decreased DA and 5-HT turnover. The present data indicate that the mechanism of action of hypericum extract in vivo is more complex than the inhibition of monoamine reuptake or metabolism observed in vitro. The finding of preferential enhancement of DA transmission is in agreement with human studies measuring DA-mediated neuroendocrine responses.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15148244      PMCID: PMC1574978          DOI: 10.1038/sj.bjp.0705822

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  20 in total

1.  Effects of catecholamine uptake blockers in the caudate-putamen and subregions of the medial prefrontal cortex of the rat.

Authors:  M S Mazei; C P Pluto; B Kirkbride; E A Pehek
Journal:  Brain Res       Date:  2002-05-17       Impact factor: 3.252

2.  Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals.

Authors:  E Carboni; G L Tanda; R Frau; G Di Chiara
Journal:  J Neurochem       Date:  1990-09       Impact factor: 5.372

3.  Inhibition of monoamine oxidase by hypericin.

Authors:  O Suzuki; Y Katsumata; M Oya; S Bladt; H Wagner
Journal:  Planta Med       Date:  1984-06       Impact factor: 3.352

4.  Effect of Hypericum perforatum (St John's wort) in major depressive disorder: a randomized controlled trial.

Authors:  Jonathan RT Davidson; Kishore M Gadde; John A Fairbank; K Ranga Rama Krishnan; Robert M Califf; Cynthia Binanay; Corette B Parker; Norma Pugh; Tyler D Hartwell; Benedetto Vitiello; Louise Ritz; Joanne Severe; Jonathan O Cole; Charles de Battista; P Murali Doraiswamy; John P Feighner; Paul Keck; Jeffrey Kelsey; Khae-Ming Lin; Peter D Londborg; Charles B Nemeroff; Alan F Schatzberg; David V Sheehan; Ram K Srivastava; Leslie Taylor; Madhukar H Trivedi; Richard H Weisler
Journal:  JAMA       Date:  2002-04-10       Impact factor: 56.272

5.  Simultaneous determination of norepinephrine, serotonin, and 5-hydroxyindole-3-acetic acid in microdialysis samples from rat brain by microbore column liquid chromatography with fluorescence detection following derivatization with benzylamine.

Authors:  Takashi Yoshitake; Kaoru Fujino; Jan Kehr; Junichi Ishida; Hitoshi Nohta; Masatoshi Yamaguchi
Journal:  Anal Biochem       Date:  2003-01-15       Impact factor: 3.365

Review 6.  Mechanism of action of St John's wort in depression : what is known?

Authors:  Veronika Butterweck
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

7.  Determination of serotonin, noradrenaline, dopamine and their metabolites in rat brain extracts and microdialysis samples by column liquid chromatography with fluorescence detection following derivatization with benzylamine and 1,2-diphenylethylenediamine.

Authors:  Takashi Yoshitake; Jan Kehr; Shimako Yoshitake; Kaoru Fujino; Hitoshi Nohta; Masatoshi Yamaguchi
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2004-08-05       Impact factor: 3.205

8.  Hyperforin inhibits vesicular uptake of monoamines by dissipating pH gradient across synaptic vesicle membrane.

Authors:  Netta Roz; Moshe Rehavi
Journal:  Life Sci       Date:  2003-06-13       Impact factor: 5.037

9.  Inhibition of MAO by fractions and constituents of hypericum extract.

Authors:  S Bladt; H Wagner
Journal:  J Geriatr Psychiatry Neurol       Date:  1994-10       Impact factor: 2.680

Review 10.  Current St John's wort research from mode of action to clinical efficacy.

Authors:  Walter E Müller
Journal:  Pharmacol Res       Date:  2003-02       Impact factor: 7.658

View more
  10 in total

1.  Computational Analysis of Therapeutic Neuroadaptation to Chronic Antidepressant in a Model of the Monoaminergic Neurotransmitter and Stress Hormone Systems.

Authors:  Mariam B Camacho; Warut D Vijitbenjaronk; Thomas J Anastasio
Journal:  Front Pharmacol       Date:  2019-10-25       Impact factor: 5.810

2.  Hyperforin activates nonselective cation channels (NSCCs).

Authors:  Kristina Treiber; Andrea Singer; Bettina Henke; Walter E Müller
Journal:  Br J Pharmacol       Date:  2005-05       Impact factor: 8.739

3.  Antidepressant-like effects of Trichilia catigua (Catuaba) extract: evidence for dopaminergic-mediated mechanisms.

Authors:  Maria M Campos; Elizabeth S Fernandes; Juliano Ferreira; Adair R S Santos; João B Calixto
Journal:  Psychopharmacology (Berl)       Date:  2005-09-29       Impact factor: 4.530

4.  Hypericum Perforatum Hydroalcoholic Extract Mitigates Motor Dysfunction and is Neuroprotective in Intrastriatal 6-Hydroxydopamine Rat Model of Parkinson's Disease.

Authors:  Zahra Kiasalari; Tourandokht Baluchnejadmojarad; Mehrdad Roghani
Journal:  Cell Mol Neurobiol       Date:  2015-06-29       Impact factor: 5.046

Review 5.  St. John's wort (Hypericum perforatum) and depression: what happens to the neurotransmitter systems?

Authors:  Gita Kholghi; Shirin Arjmandi-Rad; Mohammad-Reza Zarrindast; Salar Vaseghi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-03-16       Impact factor: 3.000

6.  Antidepressant Effects of a Persian Medicine Remedy on Multiple Sclerosis Patients: A Double-Blinded Randomized Clinical Trial.

Authors:  Maryam Adalat; Mohammad Khalili; Hormoz Ayromlou; Sajjad Haririan; Seyyed Mohammad Bagher Fazljou; Hossein Rezaeizadeh; Ali Akbar Safari; Arman Zargaran
Journal:  Galen Med J       Date:  2019-01-01

7.  MitoPark mice mirror the slow progression of key symptoms and L-DOPA response in Parkinson's disease.

Authors:  D Galter; K Pernold; T Yoshitake; E Lindqvist; B Hoffer; J Kehr; N-G Larsson; L Olson
Journal:  Genes Brain Behav       Date:  2009-10-07       Impact factor: 3.449

8.  Melatonin in antinociception: its therapeutic applications.

Authors:  Venkatramanujam Srinivasan; Edward C Lauterbach; Khek Yu Ho; Dario Acuña-Castroviejo; Rahimah Zakaria; Amnon Brzezinski
Journal:  Curr Neuropharmacol       Date:  2012-06       Impact factor: 7.363

9.  Commonly Used Dietary Supplements on Coagulation Function during Surgery.

Authors:  Chong-Zhi Wang; Jonathan Moss; Chun-Su Yuan
Journal:  Medicines (Basel)       Date:  2015-07-27

10.  Computational Model of Antidepressant Response Heterogeneity as Multi-pathway Neuroadaptation.

Authors:  Mariam B Camacho; Thomas J Anastasio
Journal:  Front Pharmacol       Date:  2017-12-20       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.